Supplying a reimbursed form of Bevacizumab 100 mg/4 ml and 400 mg/16 ml for intravenous use

Tender Notice

Tender Detail
Supplying a reimbursed form of Bevacizumab 100 mg/4 ml and 400 mg/16 ml for intravenous use
Tendering Authority
Tender Category
Other
Publish Date
06 Oct 2025
Deadline
03 Nov 2025
Country
Belgium
TenderNews Ref. No.
737416251006-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients